Comparison between deferoxamine and deferiprone (L1) in iron-loaded thalassemia patients
Abstract: Introduction: Iron-chelating therapy with deferoxamine in patients with thalassemia major has dramatically improved the prognosis of this disease. However, the limitations of this treatment have stimulated the design of alternative orally active iron chelators. Objective: To compare the ef...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , |
| Format: | article |
| Published: |
2001
|
| Online Access: | http://hdl.handle.net/10725/3921 http://dx.doi.org/10.1034/j.1600-0609.2001.067001030.x http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php http://onlinelibrary.wiley.com/doi/10.1034/j.1600-0609.2001.067001030.x/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!